NORGES BANK - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$197,802
-44.4%
66,600
-15.9%
0.00%
Q4 2021$356,000
-31.4%
79,200
-25.8%
0.00%
Q3 2021$519,000
-51.6%
106,800
-32.1%
0.00%
Q2 2021$1,072,000
-8.0%
157,200
-45.6%
0.00%
Q4 2019$1,165,000
-6.7%
289,0080.0%0.00%
Q3 2019$1,249,000
+8.3%
289,0080.0%0.00%
Q2 2019$1,153,000
-54.9%
289,008
-39.4%
0.00%
-100.0%
Q1 2019$2,557,000
+4.5%
476,9770.0%0.00%0.0%
Q4 2018$2,447,000
-47.1%
476,9770.0%0.00%
-50.0%
Q3 2018$4,627,000
-4.9%
476,9770.0%0.00%0.0%
Q2 2018$4,865,000
-21.5%
476,9770.0%0.00%0.0%
Q1 2018$6,201,000
-34.3%
476,977
-9.5%
0.00%
-33.3%
Q4 2017$9,433,000
-28.7%
526,9770.0%0.00%
-40.0%
Q3 2017$13,227,000
+74.4%
526,977
+67.5%
0.01%
+66.7%
Q2 2017$7,583,000
+308.1%
314,654
+226.1%
0.00%
+200.0%
Q1 2017$1,858,000
+25.0%
96,5000.0%0.00%0.0%
Q4 2016$1,486,000
+460.8%
96,500
+352.8%
0.00%
Q3 2016$265,000
-10.5%
21,3130.0%0.00%
Q2 2016$296,000
-8.4%
21,3130.0%0.00%
Q1 2016$323,000
-20.0%
21,3130.0%0.00%
Q4 2015$404,000
-0.2%
21,3130.0%0.00%
Q3 2015$405,000
-26.2%
21,3130.0%0.00%
Q2 2015$549,00021,3130.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders